SCHEMBL31348837

SCHEMBL31348837

O=C(O)OCC#Cc1ccc([N+](=O)[O-])cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.47
MAPT P10636 2/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
HSP90AA1 P07900 1/20 0.47
OPRK1 P41145 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
TDP1 Q9NUW8 1/20 0.43
PTPN2 P17706 1/20 0.43
PTPN1 P18031 1/20 0.43
PTPN6 P29350 1/20 0.43
PTPN11 Q06124 1/20 0.43
LMNA P02545 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
THRB P10828 1/20 0.41
CYP2C9 P11712 1/20 0.41
PKM P14618 1/20 0.41
HPGD P15428 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18657152 0.86 MAPK1 (0.45) ALDH1A1MAPTMEN1KMT2AHSP90AA1
SCHEMBL30401530 0.82 MAPT (0.42) ALDH1A1MAPTMEN1KMT2AHSP90AA1
SCHEMBL6318644 0.76 TSHR (0.48) ALDH1A1MAPTMEN1KMT2AHSP90AA1
SCHEMBL7575151 0.74 CASP3 (0.40) ALDH1A1MAPTMEN1KMT2AHSP90AA1
SCHEMBL10834444 0.74 CA12 (0.51) ALDH1A1MAPTMEN1KMT2ALMNA
SCHEMBL22398101 0.73 TSHR (0.50) ALDH1A1MAPTMEN1KMT2AHSP90AA1
SCHEMBL14664048 0.73 CASP3 (0.63) ALDH1A1MAPTMEN1KMT2AHSP90AA1
SCHEMBL10452222 0.73 CASP3 (0.47) ALDH1A1MAPTMEN1KMT2AHSP90AA1
SCHEMBL10102348 0.73 CASP3 (0.47) ALDH1A1MAPTMEN1KMT2AHSP90AA1
SCHEMBL7581502 0.73 LOXL2 (0.52) ALDH1A1MAPTMEN1KMT2AHSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119112800-A Nanoparticle for pancreatic cancer treatment by using enamine N-oxide to trigger transcytosis and crossing matrix barrier, and preparation method and application thereof 衢州市复大生物医药创新研究院 2024-12-13 CN claimed
CN-119112800-A Nanoparticle for pancreatic cancer treatment by using enamine N-oxide to trigger transcytosis and crossing matrix barrier, and preparation method and application thereof 衢州市复大生物医药创新研究院 2024-12-13 CN disclosed